University of Turku

Juha Punnonen, M.D., Ph.D. Joins Hinge Bio as Chief Development Officer

Retrieved on:

Wednesday, May 31, 2023

BURLINGAME, Calif., May 30, 2023 /PRNewswire/ -- Hinge Bio, Inc., a privately-held biotechnology company, today announced that Juha Punnonen, M.D., Ph.D. has joined the company as Chief Development Officer. Dr. Punnonen brings over 20 years of experience as a biopharmaceutical executive with a track record in building and managing R&D teams from early-stage research to development in oncology and immuno-oncology. He will lead Hinge Bio's preclinical and clinical strategy and development of product candidates generated by the company's GEM-DIMER™ technology.

Key Points:

BURLINGAME, Calif., May 30, 2023 /PRNewswire/ -- Hinge Bio, Inc., a privately-held biotechnology company, today announced that Juha Punnonen, M.D., Ph.D. has joined the company as Chief Development Officer.
He will lead Hinge Bio's preclinical and clinical strategy and development of product candidates generated by the company's GEM-DIMER™ technology.
"We are thrilled to welcome Juha to Hinge Bio," said Barry Selick, Ph.D, Chief Executive Officer of Hinge Bio.
"I am excited to join Hinge Bio to advance GEM-DIMER candidates to development," said Dr. Punnonen.

Two North Park University Students Receive Prestigious Fulbright Awards

Retrieved on:

Friday, April 28, 2023

Nobel Prize, Bachelor, University, Privacy Office of the U.S. Department of Homeland Security, Politics, Bureau, University of Turku, Research, Arab studies, Government, Student, Arabic, Pulitzer Prize, MacArthur Fellows Program, Bureau of Educational and Cultural Affairs, United, Nursing, Management, Fulbright Program

CHICAGO, April 28, 2023 /PRNewswire/ -- North Park senior Chase Friel and graduate Joel Beyar C'22 have been named recipients of the prestigious Fulbright U.S. Student Program award.

Key Points:

CHICAGO, April 28, 2023 /PRNewswire/ -- North Park senior Chase Friel and graduate Joel Beyar C'22 have been named recipients of the prestigious Fulbright U.S. Student Program award.
During the two-year program, she will receive a full-tuition scholarship and additional funds to pursue studies and research on social policy and intervention design.
Recipients of Fulbright awards are selected in an open, merit-based competition that considers leadership potential, academic and/or professional achievement, and record of service.
More than 2,000 diverse U.S. students, artists, and early career professionals in more than 100 different fields of study receive Fulbright U.S. Student Program awards annually.

New Age for Point-of-Care Diagnostics: PixCell Medical's HemoScreen Surpasses Leading Lab Hematology Analyzer Sysmex XN in Flagging of Abnormal WBC

Retrieved on:

Wednesday, November 16, 2022

Quality of life, Sysmex Corporation, WBC, Complete blood count, CBC, University, FDA, University of Turku, Red blood cell, Viscoelasticity, Solution, Medical device, Hematology

This ground-breaking study showed HemoScreen to be more accurate in regard to leukocyte abnormalities (flagging all abnormalities).

Key Points:

This ground-breaking study showed HemoScreen to be more accurate in regard to leukocyte abnormalities (flagging all abnormalities).
It demonstrated better specificity (88% versus Sysmex XN's 72%) as it was less prone to false flagging versus the Sysmex XN, this is owing to HemoScreen's novel machine learning-driven viscoelastic focusing technology.
"HemoScreen hematology analyzer is essentially comparable to Sysmex XN for CBC and WBC differential analysis.
HemoScreen was less prone to false WBC flagging compared to Sysmex XN, thereafter requiring less microscopy review.

Lisata Therapeutics’ Director and Scientific Founder of the CendR Platform™ Technology, Erkki Ruoslahti, M.D., Ph.D., Receives 2022 Albert Lasker Basic Medical Research Award

Retrieved on:

Thursday, September 29, 2022

American Academy, Lasker Award, Safety, Canada Gairdner International Award, Center, City of Hope National Medical Center, Biology, Patient, Perseverance, Nasdaq, Sanford Burnham Prebys Medical Discovery Institute, Research, Disease, University of California, Santa Barbara, National Academy of Medicine, Life, DRS, CD34, Japan Prize, University of Helsinki, Tumor microenvironment, University of Turku, RGD, National Academy of Inventors, Integrin, California Institute for Quantitative Biosciences, Director, European, Neoplasm, Physiology, City, European Molecular Biology Organization, Board of directors, Tissue, GLOBE, Peptide, Health, Therapy, Thrombosis, National academy, CendR, Japan, Pancreatic cancer, Cell adhesion, Nanomedicine, Survival, Cancer, Cell, Medical research, RNA, Heart, University, Pharmaceutical industry, Technology, Science

The Albert Lasker Basic Medical Research Award is one of the highly competitive and distinguished international prizes for medical science awarded by the Lasker Foundation.

Key Points:

The Albert Lasker Basic Medical Research Award is one of the highly competitive and distinguished international prizes for medical science awarded by the Lasker Foundation.
Lisata and its collaborators have also amassed significant non-clinical data demonstrating enhanced delivery of a range of emerging anti-cancer therapies, including immunotherapies and RNA-based therapeutics.
Lisata is exploring the potential of LSTA1 to enable a variety of treatment modalities to treat a range of solid tumors more effectively.
In addition, Lisata also has clinical development programs based on its autologous CD34+ cell therapy technology platform.

King & Spalding Adds Data Privacy Partner Jarno J. Vanto in New York

Retrieved on:

Thursday, April 7, 2022

NEW YORK, April 7, 2022 /PRNewswire/ -- King & Spalding today announced the addition of partner Jarno J. Vanto (CIPP/E, CIPP/US) to its Data, Privacy and Security practice in New York.

Key Points:

NEW YORK, April 7, 2022 /PRNewswire/ -- King & Spalding today announced the addition of partner Jarno J. Vanto (CIPP/E, CIPP/US) to its Data, Privacy and Security practice in New York.
Vanto represents clients on a host of complex international issues, including data privacy, cybersecurity, technology transactions, and governance matters.
Vanto was most recently a partner at Crowell & Moring in New York.
"I have been impressed by the footprint of King & Spalding's Data, Privacy and Security practice, both in terms of cutting-edge regulatory guidance and serving as counsel on some of the highest-profile data breach disputes," Vanto said.

Technology Innovation Institute’s Secure Systems Research Centre Collaborates with Global Universities on Secure Mesh Communications Research Projects

Retrieved on:

Tuesday, October 26, 2021

Technology Innovation Institute (TII), the applied research pillar of Abu Dhabis Advanced Technology Research Council (ATRC), today announced that its Secure Systems Research Centre (SSRC) has partnered with three prestigious universities on secure mesh communications research projects.

Key Points:

Technology Innovation Institute (TII), the applied research pillar of Abu Dhabis Advanced Technology Research Council (ATRC), today announced that its Secure Systems Research Centre (SSRC) has partnered with three prestigious universities on secure mesh communications research projects.
The project is set to strengthen the security of the Mesh network technology that TII is currently developing for machine to machine and human to human communications.
The Khalifa University project is titled A Secure and Resilient Chat/VoIP Application over Private Mesh Networks.
He noted that dependable and secure Mesh Networks are an integral part of overall communication infrastructure and will enable secure autonomous systems.